Prognostic value of loss of heterozygosity at BRCA2 in human breast carcinoma.

To confirm several recent studies pointing to loss of heterozygosity (LOH) at BRCA2 as a prognostic factor in sporadic breast cancer, we examined this genetic alteration in a large series of human primary breast tumours for which long-term patient outcomes were known. LOH at BRCA2 correlated only wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Bièche, I., Noguès, C., Rivoilan, S., Khodja, A., Latil, A., Lidereau, R.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1997
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2228174/
https://www.ncbi.nlm.nih.gov/pubmed/9400936

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2228174/
https://www.ncbi.nlm.nih.gov/pubmed/9400936

Ejemplares similares